Breaking News Instant updates and real-time market news.

BLUE

Bluebird Bio

$174.70

3.65 (2.13%)

08:31
04/19/18
04/19
08:31
04/19/18
08:31

Bluebird Bio price target raised to $232 from $223 at SunTrust

SunTrust analyst Edward Nash raised his price target on Bluebird Bio to $232 after yesterday's NEJM publication of interim data from the HGB-204 and HGB-205 studies supporting his belief that "all patients in the HGB-207 study have the potential to achieve transfusion independence". The analyst adds that based on the publication, he has "dialed up his eligible beta-thalassemia patient numbers for LentiGlobil" given the prevalence of beta-thalassemia in the U.S. and E.U. of 15,000 cases, yielding an estimate of addressable market at 7,875 vs. his prior view of 2,650. Nash keeps his Buy rating on Bluebird Bio.

  • 08

    May

BLUE Bluebird Bio
$174.70

3.65 (2.13%)

03/16/18
03/16/18
INITIATION

Bluebird Bio initiated with a Sell at Favus
03/21/18
MSCO
03/21/18
NO CHANGE
Target $209
MSCO
Equal Weight
Bluebird Bio price target to $209 from $152 at Morgan Stanley
Morgan Stanley analyst Matthew Harrison raised his price target on Bluebird Bio (BLUE) to $209 from $152, stating that he now expects BCMA therapies to take 50% of the third line market by 2030 and noting that bb2121 has 50% market share there. The new assumptions increase his peak sales forecast to about $2.6B from about $1B, he pointed out. However, Harrison keeps an Equal Weight rating on Bluebird, stating that he would expect new data to be available at ASCO in June, but would also expect to see competitor data potentially from Celgene's (CELG) Juno, Gilead's (GILD) Kite, Johnson & Johnson's (JNJ) Nanjing Legend and others.
03/28/18
03/28/18
NO CHANGE

Bluebird Bio and Celegene to co-develop bb2121 anti-BMCA therapy
Bluebird Bio (BLUE) and Celgene (CELG) announced that the companies have entered into an agreement to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen, or BCMA chimeric antigen receptor, or CAR, T cell therapy for the potential treatment of patients with relapsed/refractory multiple myeloma in the United States.The companies originally entered into a broad, global strategic research collaboration in 2013 to discover, develop and commercialize novel therapies in oncology, which included bb2121.
04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Jefferies highlights other gene theraphy players after AveXis takeover
Novartis' (NVS) deal to acquire AveXis (AVXS) for $8.7B should remind investors about the ongoing attractiveness within smid-cap biotech, Jefferies analyst Michael Yee tells investors in a research note. Novartis' two large gene therapy deals in four months will lead to a question of "who's next," the analyst adds. Yee says other mid-late stage gene therapy players include Bluebird Bio (BLUE), Spark Therapeutics (ONCE), BioMarin (BMRN), Abeona Therapeutics (ABEO), Regenxbio (RGNX), Nightstar Therapeutics (NITE) and Voyager Therapeutics (VYGR).

TODAY'S FREE FLY STORIES

ST

Sensata

$50.74

-1.14 (-2.20%)

17:13
09/24/18
09/24
17:13
09/24/18
17:13
Hot Stocks
Sensata acquires privately-held GIGAVAC FOR approximately $233M »

Sensata Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BA

Boeing

$368.04

-3.84 (-1.03%)

17:13
09/24/18
09/24
17:13
09/24/18
17:13
Hot Stocks
Boeing awarded $375.6M U.S. Air Force contract »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$337.65

-0.13 (-0.04%)

17:12
09/24/18
09/24
17:12
09/24/18
17:12
Hot Stocks
Lockheed Martin awarded $289.2M U.S. Army contract »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

EME

EMCOR

$75.06

0.04 (0.05%)

17:11
09/24/18
09/24
17:11
09/24/18
17:11
Hot Stocks
EMCOR among bidders for $475M U.S. Army contract »

EMCOR Government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$2.32

-0.035 (-1.49%)

17:08
09/24/18
09/24
17:08
09/24/18
17:08
Hot Stocks
Gemphire Therapeutics to cut 33% of staff and take a $1.4M related charge »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LKM

Link Motion

$0.62

-0.0478 (-7.12%)

17:03
09/24/18
09/24
17:03
09/24/18
17:03
Hot Stocks
Link Motion receives noncompliance notice from NYSE »

Link Motion announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$299.61

0.56 (0.19%)

17:03
09/24/18
09/24
17:03
09/24/18
17:03
Periodicals
Tesla worker says Musk called him into meeting to slam union, Bloomberg says »

Tesla employee Jose Moran…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 29

    Oct

  • 13

    Nov

BMI

Badger Meter

$54.05

-0.1 (-0.18%)

17:01
09/24/18
09/24
17:01
09/24/18
17:01
Hot Stocks
Badger Meter announces CEO Richard Meeusen will retire at year end »

Badger Meter announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 17

    Oct

KEG

Key Energy

$13.46

-0.18 (-1.32%)

, BAS

Basic Energy

$9.44

0.18 (1.94%)

17:00
09/24/18
09/24
17:00
09/24/18
17:00
Hot Stocks
Key Energy Services proposes tie-up with Basic Energy in all-stock deal »

Key Energy Services (KEG)…

KEG

Key Energy

$13.46

-0.18 (-1.32%)

BAS

Basic Energy

$9.44

0.18 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 02

    Oct

  • 03

    Oct

DAC

Danaos

$1.60

0.05 (3.23%)

16:52
09/24/18
09/24
16:52
09/24/18
16:52
Earnings
Danaos reports Q2 EPS 27c, one estimate 23c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AWK

American Water

$87.80

-0.8 (-0.90%)

16:46
09/24/18
09/24
16:46
09/24/18
16:46
Hot Stocks
American Water to spend $2M to upgrade water main in Missouri »

Missouri American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

COLD

Americold Realty Trust

$25.25

-0.09 (-0.36%)

16:45
09/24/18
09/24
16:45
09/24/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Americold Realty Trust »

Senator Investment Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRNB

Principia Biopharma

$27.34

0.24 (0.89%)

16:45
09/24/18
09/24
16:45
09/24/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Principia Biopharma »

Cormorant Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCPH

Deciphera

$39.80

0.78 (2.00%)

16:42
09/24/18
09/24
16:42
09/24/18
16:42
Initiation
Deciphera initiated  »

Deciphera initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

BJ

BJ's Wholesale

$28.47

-0.68 (-2.33%)

16:42
09/24/18
09/24
16:42
09/24/18
16:42
Syndicate
BJ's Wholesale files to sell 28M shares of common stock for holders »

BofA Merrill Lynch,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

BPMC

Blueprint Medicines

$71.56

1.8 (2.58%)

16:41
09/24/18
09/24
16:41
09/24/18
16:41
Initiation
Blueprint Medicines initiated  »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$78.57

0.53 (0.68%)

16:41
09/24/18
09/24
16:41
09/24/18
16:41
Initiation
Seattle Genetics initiated  »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$163.07

3.91 (2.46%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Loxo Oncology initiated  »

Loxo Oncology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

INCY

Incyte

$66.48

-0.11 (-0.17%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Incyte initiated  »

Incyte initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AGIO

Agios Pharmaceuticals

$75.39

1.84 (2.50%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Agios Pharmaceuticals initiated  »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMLR

Semler Scientific

$0.00

(0.00%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Hot Stocks
Breaking Hot Stocks news story on Semler Scientific »

Park West Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$32.63

0.22 (0.68%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Initiation
Clovis initiated  »

Clovis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Periodicals
Trump inks revised trade pact with South Korea, CNBC says »

U.S. president Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$36.41

-1.27 (-3.37%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Initiation
Tesaro initiated  »

Tesaro initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

BGNE

BeiGene

$166.12

2.15 (1.31%)

16:38
09/24/18
09/24
16:38
09/24/18
16:38
Initiation
BeiGene initiated  »

BeiGene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.